Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hooijer

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 25, 2019
Catecholamine excretion profiles identify clinical subgroups of neuroblastoma patientsI R N Verly, R Leen, J R Meinsma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2012
Reliability of core needle biopsy for determining ER and HER2 status in breast cancerT J A Dekker, V T H B M Smit, G K J Hooijer, et al.
Scientific Reports|June 11, 2017
Discordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysisA Creemers, E Ter Veer, L de Waal, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 18, 2020
Expression of integrin ανβ6 differentiates perihilar cholangiocarcinoma (PHC) from benign disease mimicking PHCL C Franken, F A Vuijk, E C Soer, et al.
The American Journal of Surgical Pathology|November 18, 2025
Performance Assessment of a Deep Learning-based Algorithm for Ovarian Cancer Histotyping in an Independent Data SetHein S Zelisse, Maryam Asadi-Aghbolaghi, Hossein Farahani, et al.
Translational Oncology|August 16, 2024
Tumor immune microenvironmental characteristics in Human Epidermal Growth Factor-2 (HER2) positive esophageal adenocarcinoma: A comparative analysis and biomarker studyCharlotte I Stroes, Sybren L Meijer, Geert-Jan Creemers, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 18, 2024
Transcriptome-based classification to predict FOLFIRINOX response in a real-world metastatic pancreatic cancer cohortMarjolein F Lansbergen, Mark P G Dings, Paul Manoukian, et al.
Breast Cancer Research : BCR|June 15, 2012
Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approachTim J A Dekker, Susan Ter Borg, Gerrit K J Hooijer, et al.
BJU International|May 22, 2025
A study of oral metformin for the intravesical treatment of non-muscle-invasive bladder cancerJons W van Hattum, Marinka J Remmelink, Sieb T Nuijens, et al.
Cancers|September 10, 2020
CCAAT/Enhancer-Binding Protein Delta (C/EBPδ): A Previously Unrecognized Tumor Suppressor that Limits the Oncogenic Potential of Pancreatic Ductal Adenocarcinoma CellsLeonie Hartl, JanWillem Duitman, Hella L Aberson, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|February 25, 2019
Catecholamine excretion profiles identify clinical subgroups of neuroblastoma patientsI R N Verly, R Leen, J R Meinsma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2012
Reliability of core needle biopsy for determining ER and HER2 status in breast cancerT J A Dekker, V T H B M Smit, G K J Hooijer, et al.
Scientific Reports|June 11, 2017
Discordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysisA Creemers, E Ter Veer, L de Waal, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 18, 2020
Expression of integrin ανβ6 differentiates perihilar cholangiocarcinoma (PHC) from benign disease mimicking PHCL C Franken, F A Vuijk, E C Soer, et al.
The American Journal of Surgical Pathology|November 18, 2025
Performance Assessment of a Deep Learning-based Algorithm for Ovarian Cancer Histotyping in an Independent Data SetHein S Zelisse, Maryam Asadi-Aghbolaghi, Hossein Farahani, et al.
Translational Oncology|August 16, 2024
Tumor immune microenvironmental characteristics in Human Epidermal Growth Factor-2 (HER2) positive esophageal adenocarcinoma: A comparative analysis and biomarker studyCharlotte I Stroes, Sybren L Meijer, Geert-Jan Creemers, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 18, 2024
Transcriptome-based classification to predict FOLFIRINOX response in a real-world metastatic pancreatic cancer cohortMarjolein F Lansbergen, Mark P G Dings, Paul Manoukian, et al.
Breast Cancer Research : BCR|June 15, 2012
Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approachTim J A Dekker, Susan Ter Borg, Gerrit K J Hooijer, et al.
BJU International|May 22, 2025
A study of oral metformin for the intravesical treatment of non-muscle-invasive bladder cancerJons W van Hattum, Marinka J Remmelink, Sieb T Nuijens, et al.
Cancers|September 10, 2020
CCAAT/Enhancer-Binding Protein Delta (C/EBPδ): A Previously Unrecognized Tumor Suppressor that Limits the Oncogenic Potential of Pancreatic Ductal Adenocarcinoma CellsLeonie Hartl, JanWillem Duitman, Hella L Aberson, et al.
Pageof 4